CervoMed (CRVO) Misses Q2 EPS by 27c

CervoMed (NASDAQ: CRVO) reported Q2 EPS of ($0.27). Revenue for the quarter came in at $3.29 million.

For earnings history and earnings-related data on CervoMed (CRVO) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• TechCreate Group faces NYSE American delisting proceedings
• Nvidia pitches Vera CPU to Chinese clients with August delivery target